Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 21 or older who have been diagnosed with Parkinson's disease, with recent clinical assessments completed using two standard Parkinson's rating scales (confirm with trial site for details)
- People aged 21 or older who do not have Parkinson's disease (this group serves as a comparison group)
- People who are not currently taking the medication Metformin, are able to go without eating or drinking for 8 hours, have not taken antibiotics in the past 3 months, and do not have known significant bowel or intestinal conditions
- People whose families and themselves agree to take part in the trial, including agreeing to two types of medical imaging scans — a brain glucose scan (PET scan using F-18 FDG) and a brain dopamine scan (a nuclear medicine scan) — with scan costs covered by research funds for eligible participants (confirm cost coverage details with trial site)
Who may not be able to join:
- People who are unable to undergo PET or nuclear medicine imaging scans, including those with severe anxiety disorders or unstable heart and circulation conditions
- People who are not willing to accept the small radiation exposure that comes with the imaging scans used in the study
- Women who are pregnant or currently breastfeeding
- People with Parkinson's disease who do not have recent results from the two required clinical rating scales, making it impossible to determine their stage of the condition
- People who are currently taking Metformin, cannot fast for 8 hours, have taken antibiotics within the past 3 months, or have known significant intestinal or bowel disease
- People whose families or themselves do not agree to take part in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yi-Hsien Chou, MD, NTUH Yunlin branch
Phone: +886-5-5323911
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Physiological parameter (visual score 1-3)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.